CClinicalTrials.gg
WithdrawnNCT05401981Updated Jul 31, 2025

Disjunction Between Patient Narrative and Formulaic Thinking in the Doctor

An interventional study of Story checklist in Musculoskeletal Diseases, sponsored by University of Texas at Austin. Withdrawn at 5 sites in United States. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2025-07-31.

Sponsored by University of Texas at Austin · Not applicable, Interventional, and Treatment

Why this study was withdrawn
Deemed not feasible.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years to 89 Years
Sex
All
01

Study summary

This study is seeking whether giving or not giving a clinician a card with talking points in the form of a checklist about the patient's story affects the patients care experience or not

Read the detailed description

During an office visit, the clinician and the patient engage in dialogue and begin a relationship. This traditionally starts with the patient telling their story, which conveys why they decided to seek care. This study will determine the influence of a checklist specifically about the patient's narrative. The checklist will be used during the interview portion of the visit, to remind the clinician to stay curious about the person before them, their experience of the illness, and their explanatory model, and to help ensure that empathic opportunities are not missed.

02

Conditions studied

  • Musculoskeletal Diseases

Keywords

  • Orthopedics
03

In context

Musculoskeletal Diseases

657 studies on the registry are indexed under Musculoskeletal Diseases; 159 are open to participants now.

Browse Musculoskeletal Diseases studies →

Lead sponsor

University of Texas at Austin is the lead sponsor of 319 studies on the registry; 78 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 5 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • New patients
  • Orthopedic visit

Exclusion criteria

Exclusion Criteria:

  • Languages other than English or Spanish.
  • Cognitive dysfunction precluding completion of questionnaires.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • No intervention
    Standard care

    Clinician not given any cards about the patient's story.

  • Experimental
    Story checklist

    Clinician given a card with talking points in the form of a checklist about the patient's story.

    Other: Story checklist

Interventions

  • OtherStory checklist

    The story checklist consists of a couple of questions that gives the physician something to keep in mind while visiting the patients.

06

What researchers measure

Primary outcomes

  1. Patient Experience Measure questions

    Questionnaire assessing patient's experience

    Time frame: through study completion, an average of 6 months

Secondary outcomes

  1. Perceived empathy (JSPPPE)

    Patient perceived of physician empathy as measured by the JSPPPE;The scores range from 1 ("Strongly Disagree") to 7 ("Strongly Agree"), with the total score being between 5 and 35. Higher scores represent greater empathic perception about the physician.

    Time frame: through study completion, an average of 6 months

  2. Guttman

    Patient Satisfaction as measured by the Guttman Scale, The total score is between 0 and 7, with higher scores indicating greater satisfaction.

    Time frame: through study completion, an average of 6 months

  3. Guttman CEQ

    Communication Effectiveness Questionnaire; The total score is the sum of all item scores (9 to 63) with higher scores representing a greater degree of perceived communication effectiveness.

    Time frame: through study completion, an average of 6 months

  4. PROMIS PF CAT

    Patient Physical Function is measure by the PROMIS PF CAT; Higher scores indicate better physical function, with a mean of 50 for the general US population

    Time frame: through study completion, an average of 6 months

  5. NRS pain intensity assessment

    Numeric rating scale = 11 point ordinal scale, the higher score indicates the more pain intensity

    Time frame: through study completion, an average of 6 months

07

Study locations

5 sites
  • Austin Regional Clinic
    Austin, Texas 78705, United States
  • Texas Orthopedics
    Austin, Texas 78705, United States
  • HTB Musculoskeletal Institute
    Austin, Texas 78712, United States
  • Orthopedic Specialists of Austin
    Austin, Texas 78751, United States
  • ATX Ortho
    Austin, Texas 78756, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05401981
Lead sponsor
University of Texas at Austin
Responsible party
David Ring (David Ring, MD, PhD Associate Dean for Comprehensive Care, Professor of Surgery and Psychiatry, University of Texas at Austin) — Principal investigator
First posted
Jun 2, 2022
Start date
Jan 1, 2026 (estimated)
Primary completion
Sep 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Jul 31, 2025

Study contacts

David Ring, MD, PhD
principal investigator · The University of Texas at Austin

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion